Search Results 51-60 of 15910 for GLP-1 agonist

  1. Mayo Clinic, Carnegie Mellon researchers secure ARPA-H award for multiyear implantable device research for diabetes and obesity

    The goal for the device is to produce regulated levels of glucagon-like peptide 1 (GLP ... agonists for metabolic disorders and is the ... A phase one ...

  2. Mayo Clinic Minute: Using combined therapy to treat obesity INTRO: Research shows that metabolic surgery and GLP-1 medications a

    Page 1. Mayo Clinic Minute: Using combined therapy to treat obesity. INTRO: Research shows that metabolic surgery and GLP-1 medications are both effective ...

  3. Complex bariatric surgery for high-risk patients and revision of past procedures - Mayo Clinic

    Despite the increased demand for glucagon-like peptide-1 receptor agonists (GLP-1 RAs), surgical procedures will continue to play a vital role in medical weight ...

  4. Glucagon (nasal route) - Side effects & dosage - Mayo Clinic

    However, safety and efficacy of glucagon nasal powder have not been established in children younger than 1 year of age. Geriatric. Appropriate studies performed ...

  5. A Study To Test The Effect Of BI 456906 On Cardiovascular Safety In People With Overweight Or Obesity (SYNCHRONIZE™ - CVOT) - Mayo Clinic

    Previous treatment with glucagon-like peptide-1 receptor (GLP-1R) agonists within 3 months before screening. ... Less than 3 months between the last dose of GLP- ...

  6. Publications - Juan P. Brito Campana, M.B.B.S. - Mayo Clinic

    Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08. View PubMed ...

  7. Publications - George W. Marek, III, M.D., Ph.D. - Mayo Clinic

    ... glucagon-like peptide-1 receptor agonist use. Dis Esophagus. 2025 Nov 1; 38 (6) View PubMed; Marek G. Not so subclinical: Is early thyroid disease an ...

  8. Diabetes Clinical Trials - Mayo Clinic Research

    The overall goal of this proposal is to determine the effects of acute hyperglycemia and its modulation by Glucagon-like Peptide-1 (GLP-1) on myocardial ...

  9. Publications - George W. Marek, III, M.D., Ph.D. - Mayo Clinic

    ... glucagon-like peptide-1 receptor agonist use. Dis Esophagus. 2025 Nov 1; 38 (6) View PubMed; Marek G. Not so subclinical: Is early thyroid disease an ...

  10. Manal F. Abdelmalek, M.D. - Mayo Clinic Faculty Profiles

    ... glucagon-like peptide-1 agonists, pan-peroxisome proliferator-activated receptor agonists and fibroblast growth factor-21 agonists. Repurposed medicines for ...